Proceedings of the Conference on Health, Inference, and Learning 2021
DOI: 10.1145/3450439.3451875
|View full text |Cite
|
Sign up to set email alerts
|

Enabling counterfactual survival analysis with balanced representations

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
71
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(71 citation statements)
references
References 19 publications
0
71
0
Order By: Relevance
“…The recently proposed continuous-time SA based counterfactual survival analysis (CSA) [33] and discrete-time SA based SurvITE [34] are the only techniques for heterogeneous and personalized CI in SA datasets. Both these models optimize the average (heterogeneous) treatment effect via counterfactual prediction of survival outcomes in observational studies, while leveraging on the balanced representation learning [6].…”
Section: Related Work and Noveltymentioning
confidence: 99%
See 2 more Smart Citations
“…The recently proposed continuous-time SA based counterfactual survival analysis (CSA) [33] and discrete-time SA based SurvITE [34] are the only techniques for heterogeneous and personalized CI in SA datasets. Both these models optimize the average (heterogeneous) treatment effect via counterfactual prediction of survival outcomes in observational studies, while leveraging on the balanced representation learning [6].…”
Section: Related Work and Noveltymentioning
confidence: 99%
“…• ACTG-Semi synthetic dataset: The AIDS Clinical Trials Group (ACTG) is an RCT study [42]. Generation of the semi-synthetic dataset based on covariates from ACTG is as described in [33]. Generation of the semi-synthetic dataset based on covariates from ACTG is as described in [33].…”
Section: A Datasetsmentioning
confidence: 99%
See 1 more Smart Citation
“…Potential outcomes can then be estimated by changing the respective treatment covariate or model. These naive approaches are occasionally discussed in performance comparisons, e.g., in (Chapfuwa et al, 2020;Curth et al, 2021). An alternative approach is to match similar patients between treated and non-treated populations using, e.g., propensity scores (Rosenbaum and Rubin, 1983).…”
Section: Introductionmentioning
confidence: 99%
“…Nonparametrically investigating treatment effect heterogeneity, however, has been studied in much less detail in the survival context. While a number of tree-based methods have been proposed recently [23,24,25,26], NN-based methods lack extensions to the time-to-event setting despite their successful adoption for estimating the effects of treatments on other outcomes -the only exception being [27], who directly model event times under different treatments with generative models.…”
Section: Introductionmentioning
confidence: 99%